A randomized, double-blind, single-dose, three-arm, parallel group study to determine pharmacokinetic similarity of ABP 959 and eculizumab (Soliris® ) in healthy male subjects.

Saved in:
Bibliographic Details
Title: A randomized, double-blind, single-dose, three-arm, parallel group study to determine pharmacokinetic similarity of ABP 959 and eculizumab (Soliris® ) in healthy male subjects.
Authors: Chow V; Amgen Inc., Thousand Oaks, CA, USA., Pan J; Amgen Inc., Thousand Oaks, CA, USA., Chien D; Amgen Inc., Thousand Oaks, CA, USA., Mytych DT; Amgen Inc., Thousand Oaks, CA, USA., Hanes V; Amgen Inc., Thousand Oaks, CA, USA.
Source: European journal of haematology [Eur J Haematol] 2020 Jul; Vol. 105 (1), pp. 66-74. Date of Electronic Publication: 2020 Apr 27.
Publication Type: Journal Article; Randomized Controlled Trial
Journal Info: Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609 (Electronic) Linking ISSN: 09024441 NLM ISO Abbreviation: Eur J Haematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first